AU Stock MarketDetailed Quotes

MSB Mesoblast Ltd

Watchlist
  • 2.530
  • +0.110+4.55%
20min DelayMarket Closed Dec 23 16:00 AET
2.89BMarket Cap-0.19P/E (Static)

Mesoblast Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mesoblast Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q2 -- / 3.382M --
-- 2025/Q1 -- / 1.193M --
Aug 29, 2024 2024/Q4 -- / 6.612M --
-- 2024/Q3 -- / 0.000 --
Feb 29, 2024 2024/Q2 -- / 5.761M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 3.382M--
--2025/Q1-- / 1.193M--
Aug 29, 20242024/Q4-- / 6.612M--
--2024/Q3-- / 0.000--
Feb 29, 20242024/Q2-- / 5.761M--

Unlock Free Earnings Estimates

Mesoblast Ltd Earnings Reports

  • Mesoblast Ltd: Annual Report to Shareholders

    Oct 17 10:29

  • Mesoblast Ltd: Annual Financial Results Presentation

    Aug 29 06:13

  • Mesoblast Ltd: Preliminary Final Report including Appendix 4E

    Aug 29 06:01

  • Mesoblast Ltd: MSB Q2 Financial Results and Operational Highlights

    Feb 29 05:54

    • Read more

    Trending AU Stocks
    ASX High Dividend ASX High Dividend
    Symbol Mini Chart % Chg
    CommBank
    CBA
    +2.94%
    Origin Energy Ltd
    ORG
    +2.56%
    ANZ Group Holdings Ltd
    ANZ
    +2.36%
    National Australia Bank Ltd
    NAB
    +2.12%
    Westpac Banking Corp
    WBC
    +1.96%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Aug 29, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      0.00%

    • Hold

      20.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Healthcare - Cancer Research
    Healthcare - Cancer Research
    Intraday+0.57%